Compelling evidence links chronic activation of glia and the subsequent cyc
le of neuroinflammation and neuronal dysfunction to the progression of neur
odegeneration in disorders such as Alzheimer's disease (AD). S100B, a glial
-derived cytokine, is significantly elevated in the brains of AD patients a
nd high concentrations of SlOOB are believed to be detrimental to brain fun
ction. As a first step toward elucidating the mechanisms by which SlOOB mig
ht be serving this detrimental role, we examined the mechanisms by which S1
00B stimulates glial inducible nitric oxide synthase (iNOS), an oxidative s
tress related enzyme that has been linked to neuropathology through the pro
duction of neurotoxic peroxynitrite. We report here that S100B stimulates i
NOS in rat primary cortical astrocytes through a signal transduction pathwa
y that involves activation of the transcription factor NF kappaB. NTF kappa
B activation was demonstrated by nuclear translocation of the p65 NF kappaB
subunit, stimulation of NF kappaB-specific DNA binding activity, and stimu
lation of NF kappaB-dependent transcriptional activity. Furthermore, S100B-
induced iNOS promoter activation was inhibited upon mutation of the NF kapp
aB response element in the promoter, and transfection of cells with an NTF
kappaB inhibitor blocked S100B-induced iNOS promoter activation and nitric
oxide production. These studies define a signal transduction pathway by whi
ch S100B activation of glia could participate in the generation of oxidativ
e stress in the brain. (C) 2001 Elsevier Science Inc. All rights reserved.